[Identification of Mycoplasma in patients with suspected prostate cancer]
- PMID: 20799402
[Identification of Mycoplasma in patients with suspected prostate cancer]
Abstract
Aim: Tests for Mycoplasma hominis, M. genitalium, Ureaplasma urealyticum in males with suspected prostate cancer.
Materials and methods: Identification of mycoplasms was performed in prostate tissue samples using universal PCR as well as in serum samples of patients with suspected prostate cancer using ELISA for detection of IgG to M. hominis. Two hundred and fifty samples from each lobe of prostate were obtained from 125 patients with suspected prostate cancer by transrectal polyfocal biopsy. Blood samples were drawn from the same patients for ELISA.
Results: Out of 125 patients with suspected prostate cancer, 20.5% were positive for Mycoplasma by PCR. Between studied species, only M. hominis was found in big proportion of analyzed samples. Out of 118 serum samples, 30.5% were positive for IgG to M. hominis in ELISA.
Conclusion: Fact of presence of Mycoplasma species in tissue of prostate was established in 20.5% pf patients with suspected prostate cancer. Obtained results show that M. hominis is frequently infects prostate tissue and that this infection was more common in patients with high grade prostatic interstitial neoplasia and prostate cancer than in patients with benign changes of prostate tissue or in persons without prostate disease. This allows to suggest that infection with M. hominis could play an important role in development of cancer.
Similar articles
-
Detection of Chlamydia trachomatis and Mycoplasma hominis, genitalium and Ureaplasma urealyticum by polymerase chain reaction in patients with sterile pyuria.Adv Med Sci. 2008;53(1):80-6. doi: 10.2478/v10039-008-0020-1. Adv Med Sci. 2008. PMID: 18614434
-
Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: An Italian observational multicentre study.J Microbiol Immunol Infect. 2018 Apr;51(2):220-225. doi: 10.1016/j.jmii.2017.05.004. Epub 2017 Jun 28. J Microbiol Immunol Infect. 2018. PMID: 28711440
-
Simultaneous detection of Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma genitalium and Mycoplasma hominis by fluorescence polarization.J Biotechnol. 2010 Oct 1;150(1):41-3. doi: 10.1016/j.jbiotec.2010.07.024. Epub 2010 Jul 29. J Biotechnol. 2010. PMID: 20673839
-
Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: a systematic review and meta-analysis.Arch Gynecol Obstet. 2018 Jun;297(6):1377-1387. doi: 10.1007/s00404-018-4733-5. Epub 2018 Mar 8. Arch Gynecol Obstet. 2018. PMID: 29520664
-
Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1845-1851. doi: 10.1111/jdv.15146. Epub 2018 Jul 6. J Eur Acad Dermatol Venereol. 2018. PMID: 29924422 Review.
Cited by
-
Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology.Tumour Biol. 2016 Aug;37(8):10805-13. doi: 10.1007/s13277-016-4970-9. Epub 2016 Feb 13. Tumour Biol. 2016. PMID: 26874727
-
Prediction of mycoplasma hominis proteins targeting in mitochondria and cytoplasm of host cells and their implication in prostate cancer etiology.Oncotarget. 2017 May 9;8(19):30830-30843. doi: 10.18632/oncotarget.8306. Oncotarget. 2017. PMID: 27027344 Free PMC article.
-
To Decipher the Mycoplasma hominis Proteins Targeting into the Endoplasmic Reticulum and Their Implications in Prostate Cancer Etiology Using Next-Generation Sequencing Data.Molecules. 2018 Apr 24;23(5):994. doi: 10.3390/molecules23050994. Molecules. 2018. PMID: 29695086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical